Coston, McIsaac & Partners
- SEC CIK
- 0001945037
- Latest filing
- Aug 12, 2026
PFE holding history
Pfizer Inc in every 13F filed by Coston, McIsaac & Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 14,289
- Value
- $344.0K
- % of portfolio
- 0.1%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 14,289 | $344.0K | 0.1% | +82+0.6% | Added | Holders |
| Q1 2026 | 14,207 | $398.0K | 0.1% | +102+0.7% | Added | Holders |
| Q4 2025 | 14,105 | $351.0K | 0.1% | −366−2.5% | Reduced | Holders |
| Q3 2025 | 14,471 | $368.0K | 0.1% | +172+1.2% | Added | Holders |
| Q2 2025 | 14,299 | $346.0K | 0.1% | −4,023−22.0% | Reduced | Holders |
| Q1 2025 | 18,322 | $464.0K | 0.1% | +2,328+14.6% | Added | Holders |
| Q4 2024 | 15,994 | $424.0K | 0.1% | −3,099−16.2% | Reduced | Holders |
| Q3 2024 | 19,093 | $552.0K | 0.2% | −443−2.3% | Reduced | Holders |
| Q2 2024 | 19,536 | $546.0K | 0.2% | +1,034+5.6% | Added | Holders |
| Q1 2024 | 18,502 | $513.0K | 0.2% | +633+3.5% | Added | Holders |
| Q4 2023 | 17,869 | $514.0K | 0.2% | +98+0.6% | Added | Holders |
| Q3 2023 | 17,771 | $589.0K | 0.2% | +70+0.4% | Added | Holders |
| Q2 2023 | 17,701 | $649.0K | 0.2% | +72+0.4% | Added | Holders |
| Q1 2023 | 17,629 | $719.0K | 0.3% | +635+3.7% | Added | Holders |
| Q4 2022 | 16,994 | $870.0K | 0.3% | −130−0.8% | Reduced | Holders |
| Q3 2022 | 17,124 | $749.0K | 0.3% | +33+0.2% | Added | Holders |
| Q2 2022 | 17,091 | $896.0K | 0.5% | – | No prior filing | Holders |